- Home
- BGI vs COCH Comparison
BGI vs COCH Comparison
Compare BGI & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | BGI | COCH |
|---|---|---|
| Founded | 1879 | 1995 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Blank Checks |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.7M | 24.4M |
| IPO Year | 2005 | N/A |
Fundamental Metrics
Financial Performance| Metric | BGI | COCH |
|---|---|---|
| Price | $1.04 | $0.69 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $9.50 |
| AVG Volume (30 Days) | 49.4K | ★ 167.2K |
| Earning Date | 12-05-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $136,846,182.00 | $208,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $29.53 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 7.45 | N/A |
| 52 Week Low | $0.56 | $0.64 |
| 52 Week High | $2.03 | $1.91 |
Technical Indicators
Market Signals| Indicator | BGI | COCH |
|---|---|---|
| Relative Strength Index (RSI) | 60.70 | 44.74 |
| Support Level | $0.85 | $0.66 |
| Resistance Level | $1.12 | $0.70 |
| Average True Range (ATR) | 0.05 | 0.04 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 69.98 | 44.07 |
Price Performance
Historical ComparisonAbout BGI Birks Group Inc.
Birks Group Inc is a part of the leisure industry. The company designs, develops, produces, and retails fine jewelry, timepieces, and gifts. Its operating segments include Retail and Other. The company generates maximum revenue from the Retail segment. Its retail segment consists of retail operations whereby it operates stores in Canada under the Maison Birks, Brinkhaus, Graff, and Patek Phillippe brands. The other segment consists mainly of wholesale business, e-commerce business, and gold exchange business.
About COCH Envoy Medical Inc.
Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.